| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J B Guarnaccia, A Khan, R Ayettey, J A Treu, B Comerford, V Y Njik. Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis. Multiple sclerosis and related disorders. vol 50. 2021-05-14. PMID:33636612. |
patterns of medical cannabis use among patients diagnosed with multiple sclerosis. |
2021-05-14 |
2023-08-13 |
Not clear |
| J B Guarnaccia, A Khan, R Ayettey, J A Treu, B Comerford, V Y Njik. Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis. Multiple sclerosis and related disorders. vol 50. 2021-05-14. PMID:33636612. |
to survey the pattern and benefits of medical cannabis use (mcu) in a cross section of persons with multiple sclerosis (pwms). |
2021-05-14 |
2023-08-13 |
Not clear |
| Shashank Kumar Maurya, Neetu Bhattacharya, Suman Mishra, Amit Bhattacharya, Pratibha Banerjee, Sabyasachi Senapati, Rajnikant Mishr. Microglia Specific Drug Targeting Using Natural Products for the Regulation of Redox Imbalance in Neurodegeneration. Frontiers in pharmacology. vol 12. 2021-05-02. PMID:33927630. |
the possible interventions by curcumin, resveratrol, cannabidiol, ginsenosides, flavonoids and sulforaphane on microglia specific protein iba1 suggest possibility of natural products mediated regulation of microglia phenotypes and its functions to control redox imbalance and neuroinflammation in management of alzheimer's, parkinson's and multiple sclerosis for microglia-mediated therapeutics. |
2021-05-02 |
2023-08-13 |
Not clear |
| Carmen Navarrete, Adela García-Martín, Alain Rolland, Jim DeMesa, Eduardo Muño. Cannabidiol and Other Cannabinoids in Demyelinating Diseases. International journal of molecular sciences. vol 22. issue 6. 2021-04-23. PMID:33804243. |
a growing body of preclinical evidence indicates that certain cannabinoids, including cannabidiol (cbd) and synthetic derivatives, may play a role in the myelinating processes and are promising small molecules to be developed as drug candidates for management of demyelinating diseases such as multiple sclerosis (ms), stroke and traumatic brain injury (tbi), which are three of the most prevalent demyelinating disorders. |
2021-04-23 |
2023-08-13 |
Not clear |
| Jessica Rice, Cinda Hugos, Andrea Hildebrand, Michelle Camero. Cannabis use in people with multiple sclerosis and spasticity: A cross-sectional analysis. Multiple sclerosis and related disorders. vol 41. 2021-03-22. PMID:32086163. |
cannabis use in people with multiple sclerosis and spasticity: a cross-sectional analysis. |
2021-03-22 |
2023-08-13 |
Not clear |
| Wessam Mustafa, Nadia Elgendy, Samer Salama, Mohamed Jawad, Khaled Eltoukh. The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis. Multiple sclerosis international. vol 2021. 2021-02-26. PMID:33628507. |
the effect of cannabis on the clinical and cytokine profiles in patients with multiple sclerosis. |
2021-02-26 |
2023-08-13 |
Not clear |
| Wessam Mustafa, Nadia Elgendy, Samer Salama, Mohamed Jawad, Khaled Eltoukh. The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis. Multiple sclerosis international. vol 2021. 2021-02-26. PMID:33628507. |
multiple studies have reported that cannabis administration in multiple sclerosis patients is associated with decreased symptom severity. |
2021-02-26 |
2023-08-13 |
Not clear |
| Wessam Mustafa, Nadia Elgendy, Samer Salama, Mohamed Jawad, Khaled Eltoukh. The Effect of Cannabis on the Clinical and Cytokine Profiles in Patients with Multiple Sclerosis. Multiple sclerosis international. vol 2021. 2021-02-26. PMID:33628507. |
this study was conducted to evaluate the prevalence of cannabis abuse in multiple sclerosis cases and to evaluate the effect of cannabis on serum cytokines in such cases. |
2021-02-26 |
2023-08-13 |
Not clear |
| Zaid H Maayah, Shingo Takahara, Mourad Ferdaoussi, Jason R B Dyc. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. vol 69. issue 6. 2021-02-23. PMID:32239248. |
the anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. |
2021-02-23 |
2023-08-13 |
Not clear |
| Zaid H Maayah, Shingo Takahara, Mourad Ferdaoussi, Jason R B Dyc. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. vol 69. issue 6. 2021-02-23. PMID:32239248. |
the presence of all these bioactive molecules in cannabis extracts has garnered much attention of late especially with regard to their potential role in the treatment of neuropathic pain associated with multiple sclerosis. |
2021-02-23 |
2023-08-13 |
Not clear |
| Clara Grazia Chisari, Claudio Solaro, Pasquale Annunziata, Roberto Bergamaschi, Assunta Bianco, Simona Bonavita, Vincenzo Brescia Morra, Roberto Bruno Bossio, Elisabetta Capello, Letizia Castelli, Paola Cavalla, Gianfranco Costantino, Diego Centonze, Salvatore Cottone, Maura Chiara Danni, Federica Esposito, Alberto Gajofatto, Claudio Gasperini, Angelica Guareschi, Roberta Lanzillo, Giacomo Lus, Giorgia Teresa Maniscalco, Manuela Matta, Damiano Paolicelli, Loredana Petrucci, Simona Pontecorvo, Isabella Righini, Marco Rovaris, Edoardo Sessa, Gabriella Spinicci, Daniele Spitaleri, Paola Valentino, Mauro Zaffaroni, Mario Zappia, Francesco Patt. Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. Journal of neurology, neurosurgery, and psychiatry. vol 91. issue 9. 2021-01-25. PMID:32661083. |
delta-δ-tetrahydrocannabinol and cannabidiol (thc:cbd) oromucosal spray is used as an add-on therapy option for moderate to severe multiple sclerosis (ms) spasticity resistant to other medications. |
2021-01-25 |
2023-08-13 |
Not clear |
| Andrea Hildebrand, Jessica Minnier, Michelle H Camero. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada. Multiple sclerosis and related disorders. vol 38. 2021-01-19. PMID:31855842. |
cannabis use for symptom relief in multiple sclerosis: a cross-sectional survey of webinar attendees in the us and canada. |
2021-01-19 |
2023-08-13 |
Not clear |
| Andrea Hildebrand, Jessica Minnier, Michelle H Camero. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada. Multiple sclerosis and related disorders. vol 38. 2021-01-19. PMID:31855842. |
with the expansion of medical and recreational legalization of cannabis, there is growing interest in cannabis use by people with multiple sclerosis (ms). |
2021-01-19 |
2023-08-13 |
Not clear |
| Craig D Workman, John H Kindred, Laura L Boles Ponto, John Kamholz, Thorsten Rudrof. The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. vol 45. issue 4. 2021-01-06. PMID:31841355. |
the effects of chronic Δ-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) use on cerebral glucose metabolism in multiple sclerosis: a pilot study. |
2021-01-06 |
2023-08-13 |
Not clear |
| Craig D Workman, John H Kindred, Laura L Boles Ponto, John Kamholz, Thorsten Rudrof. The effects of chronic Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. vol 45. issue 4. 2021-01-06. PMID:31841355. |
this exploratory pilot study investigated the effects of chronic Δ-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) on cerebral glucose metabolism in people with multiple sclerosis (pwms). |
2021-01-06 |
2023-08-13 |
Not clear |
| Daniela De Vita, Valentina Noemi Madia, Valeria Tudino, Francesco Saccoliti, Alessandro De Leo, Antonella Messore, Patrizia Roscilli, Alfonso Botto, Ivano Pindinello, Gianluigi Santilli, Luigi Scipione, Roberta Costi, Roberto Di Sant. Comparison of different methods for the extraction of cannabinoids from cannabis. Natural product research. vol 34. issue 20. 2020-11-04. PMID:31035854. |
cannabis oils, namely concentrated cannabis extracts, are getting plenty of attention because of their therapeutic potential for treatment of patients with cancer, hiv, multiple sclerosis and several other pathologies. |
2020-11-04 |
2023-08-13 |
Not clear |
| Xiaoming Yang, Marpe Bam, Prakash S Nagarkatti, Mitzi Nagarkatt. Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis. Scientific reports. vol 9. issue 1. 2020-10-28. PMID:31673072. |
cannabidiol (cbd) has been shown by our laboratory to attenuate experimental autoimmune encephalomyelitis (eae), an animal model of multiple sclerosis (ms). |
2020-10-28 |
2023-08-13 |
mouse |
| Zinah Zamil Al-Ghezi, Kathryn Miranda, Mitzi Nagarkatti, Prakash S Nagarkatt. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Frontiers in immunology. vol 10. 2020-10-19. PMID:31497013. |
combination of cannabinoids, Δ9- tetrahydrocannabinol and cannabidiol, ameliorates experimental multiple sclerosis by suppressing neuroinflammation through regulation of mirna-mediated signaling pathways. |
2020-10-19 |
2023-08-13 |
mouse |
| Bennis Pavisian, W Richard Staines, Anthony Feinstei. Cannabis-induced alterations in brain activation during a test of information processing speed in patients with MS. Multiple sclerosis journal - experimental, translational and clinical. vol 1. 2020-10-01. PMID:28607694. |
the objective of this article is to determine the functional brain correlates of information processing speed in multiple sclerosis (ms) patients who smoke cannabis and those who are drug naïve. |
2020-10-01 |
2023-08-13 |
Not clear |
| Viral P Patel, Anthony Feinstei. Cannabis and cognitive functioning in multiple sclerosis: The role of gender. Multiple sclerosis journal - experimental, translational and clinical. vol 3. issue 2. 2020-10-01. PMID:28634543. |
cannabis and cognitive functioning in multiple sclerosis: the role of gender. |
2020-10-01 |
2023-08-13 |
Not clear |